|
1
|
Seto E and Yoshida M: Erasers of Histone
Acetylation. The Histone Deacetylase Enzymes. Cold Spring Harb
Perspect Biol. 6:a0187132014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Marks P, Rifkind RA, Richon VM, Breslow R,
Miller T and Kelly WK: Histone deacetylases and cancer: Causes and
therapies. Nat Rev Cancer. 1:194–202. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ropero S and Esteller M: The role of
histone deacetylases (HDACs) in human cancer. Mol. Oncol. 1:19–25.
2007.
|
|
4
|
Juengel E, Meyer dos Santos S, Schneider
T, Makarevic J, Hudak L, Bartsch G, Haferkamp A, Wiesner C and
Blaheta RA: HDAC inhibition suppresses bladder cancer cell adhesion
to collagen under flow conditions. Exp Biol Med (Maywood).
238:1297–1304. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Munster PN, Troso-Sandoval T, Rosen N,
Rifkind R, Marks PA and Richon VM: The histone deacetylase
inhibitor suberoylanilide hydroxamic acid induces differentiation
of human breast cancer cells. Cancer Res. 61:8492–8497.
2001.PubMed/NCBI
|
|
6
|
Komatsu N, Kawamata N, Takeuchi S, Yin D,
Chien W, Miller CW and Koeffler HP: SAHA, a HDAC inhibitor, has
profound anti-growth activity against non-small cell lung cancer
cells. Oncol Rep. 15:187–191. 2006.PubMed/NCBI
|
|
7
|
Wilson AJ, Byun DS, Popova N, Murray LB,
L'Italien K, Sowa Y, Arango D, Velcich A, Augenlicht LH and
Mariadason JM: Histone deacetylase 3 (HDAC3) and other class I
HDACs regulate colon cell maturation and p21 expression and are
deregulated in human colon cancer. J Biol Chem. 281:13548–13558.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sakuma T, Uzawa K, Onda T, Shiiba M, Yokoe
H, Shibahara T and Tanzawa H: Aberrant expression of histone
deacetylase 6 in oral squamous cell carcinoma. Int J Oncol.
29:117–124. 2006.PubMed/NCBI
|
|
9
|
Zhao R, Chen K, Cao J, Yu H, Tian L and
Liu M: A correlation analysis between HDAC1 over-expression and
clinical features of laryngeal squamous cell carcinoma. Acta
Otolaryngol. 136:172–176. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
de Ruijter AJ, van Gennip AH, Caron HN,
Kemp S and van Kuilenburg AB: Histone deacetylases (HDACs):
Characterization of the classical HDAC family. Biochem J.
370:737–749. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Khan N, Jeffers M, Kumar S, Hackett C,
Boldog F, Khramtsov N, Qian X, Mills E, Berghs SC, Carey N, et al:
Determination of the class and isoform selectivity of
small-molecule histone deacetylase inhibitors. Biochem J.
409:581–589. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chikamatsu K, Ishii H, Murata T, Sakakura
K, Shino M, Toyoda M, Takahashi K and Masuyama K: Alteration of
cancer stem cell-like phenotype by histone deacetylase inhibitors
in squamous cell carcinoma of the head and neck. Cancer Sci.
104:1468–1475. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Meng J, Zhang HH, Zhou CX, Li C, Zhang F
and Mei QB: The histone deacetylase inhibitor trichostatin A
induces cell cycle arrest and apoptosis in colorectal cancer cells
via p53-dependent and -independent pathways. Oncol Rep. 28:384–388.
2012.PubMed/NCBI
|
|
14
|
Anh TD, Ahn MY, Kim SA, Yoon JH and Ahn
SG: The histone deacetylase inhibitor, Trichostatin A, induces G2/M
phase arrest and apoptosis in YD-10B oral squamous carcinoma cells.
Oncol Rep. 27:455–460. 2012.PubMed/NCBI
|
|
15
|
Massagué J: G1 cell-cycle control and
cancer. Nature. 432:298–306. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang W and Liu HT: MAPK signal pathways
in the regulation of cell proliferation in mammalian cells. Cell
Res. 12:9–18. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chou CW, Wu MS, Huang WC and Chen CC: HDAC
inhibition decreases the expression of EGFR in colorectal cancer
cells. PLoS One. 6:e180872011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Koster MI, Kim S, Mills AA, DeMayo FJ and
Roop DR: p63 is the molecular switch for initiation of an
epithelial stratification program. Genes Dev. 18:126–131. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Weber A, Bellmann U, Bootz F, Wittekind C
and Tannapfel A: Expression of p53 and its homologues in primary
and recurrent squamous cell carcinomas of the head and neck. Int J
Cancer. 99:22–28. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rocco JW, Leong CO, Kuperwasser N, DeYoung
MP and Ellisen LW: p63 mediates survival in squamous cell carcinoma
by suppression of p73-dependent apoptosis. Cancer Cell. 9:45–56.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
DeYoung MP, Johannessen CM, Leong CO,
Faquin W, Rocco JW and Ellisen LW: Tumor-specific p73 up-regulation
mediates p63 dependence in squamous cell carcinoma. Cancer Res.
66:9362–9368. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ramsey MR, He L, Forster N, Ory B and
Ellisen LW: Physical association of HDAC1 and HDAC2 with p63
mediates transcriptional repression and tumor maintenance in
squamous cell carcinoma. Cancer Res. 71:4373–4379. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Martìn-Padura I, Lostaglio S, Schneemann
M, Williams S, Romano M, Fruscella P, Panzeri C, Stoppacciaro A,
Ruco L, Villa A, et al: Junctional adhesion molecule, a novel
member of the immunoglobulin superfamily that distributes at
intercellular junctions and modulates monocyte transmigration. J
Cell Biol. 142:117–127. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tsukita S, Furuse M and Itoh M:
Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol.
2:285–293. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
McSherry EA, Brennan K, Hudson L, Hill ADK
and Hopkins AM: Breast cancer cell migration is regulated through
junctional adhesion molecule-A-mediated activation of Rap1 GTPase.
Breast Cancer Res. 13:R312011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Severson EA, Lee WY, Capaldo CT, Nusrat A
and Parkos CA: Junctional adhesion molecule A interacts with Afadin
and PDZ-GEF2 to activate Rap1A, regulate beta1 integrin levels, and
enhance cell migration. Mol Biol Cell. 20:1916–1925. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kakuki T, Kurose M, Takano K, Kondoh A,
Obata K, Nomura K, Miyata R, Kaneko Y, Konno T, Takahashi S, et al:
Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in
head and neck squamous cell carcinoma. Oncotarget. 7:33887–33900.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Furuse M, Hata M, Furuse K, Yoshida Y,
Haratake A, Sugitani Y, Noda T, Kubo A and Tsukita S: Claudin-based
tight junctions are crucial for the mammalian epidermal barrier: A
lesson from claudin-1-deficient mice. J Cell Biol. 156:1099–1111.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lopardo T, Lo Iacono N, Marinari B,
Giustizieri ML, Cyr DG, Merlo G, Crosti F, Costanzo A and Guerrini
L: Claudin-1 is a p63 target gene with a crucial role in epithelial
development. PLoS One. 3:e27152008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dos Reis PP, Bharadwaj RR, Machado J,
Macmillan C, Pintilie M, Sukhai MA, Perez-Ordonez B, Gullane P,
Irish J and Kamel-Reid S: Claudin 1 overexpression increases
invasion and is associated with aggressive histological features in
oral squamous cell carcinoma. Cancer. 113:3169–3180. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sappayatosok K and Phattarataratip E:
Overexpression of Claudin-1 is associated with advanced clinical
stage and invasive pathologic characteristics of oral squamous cell
carcinoma. Head Neck Pathol. 9:173–180. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kondoh A, Takano K, Kojima T, Ohkuni T,
Kamekura R, Ogasawara N, Go M, Sawada N and Himi T: Altered
expression of claudin-1, claudin-7, and tricellulin regardless of
human papilloma virus infection in human tonsillar squamous cell
carcinoma. Acta Otolaryngol. 131:861–868. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Oku N, Sasabe E, Ueta E, Yamamoto T and
Osaki T: Tight junction protein claudin-1 enhances the invasive
activity of oral squamous cell carcinoma cells by promoting
cleavage of laminin-5 gamma2 chain via matrix metalloproteinase
(MMP)-2 and membrane-type MMP-1. Cancer Res. 66:5251–5257. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Takano K, Kakuki T, Obata K, Nomura K,
Miyata R, Kondo A, Kurose M, Kakiuchi A, Kaneko Y, Kohno T, et al:
The behavior and role of lipolysis-stimulated lipoprotein receptor,
a component of tricellular tight junctions, in head and neck
squamous cell carcinomas. Anticancer Res. 36:5895–5904. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Leech AO, Cruz RG, Hill AD and Hopkins AM:
Paradigms lost-an emerging role for over-expression of tight
junction adhesion proteins in cancer pathogenesis. Ann Trans Med.
3:1842015.
|
|
36
|
Tian Y, Tian Y, Zhang W, Wei F, Yang J,
Luo X, Zhou T, Hou B, Qian S, Deng X, et al: Junctional adhesion
molecule-A, an epithelial-mesenchymal transition inducer,
correlates with metastasis and poor prognosis in human
nasopharyngeal cancer. Carcinogenesis. 36:41–48. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zang M, Luo W, Huang B, Liu Z, Sun L,
Zhang Q, Qiu X, Xu K and Wang E: Overexpression of JAM-A in
non-small cell lung cancer correlates with tumor progression. PLoS
One. 8:e791732013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ikeo K, Oshima T, Shan J, Matsui H, Tomita
T, Fukui H, Watari J and Miwa H: Junctional adhesion molecule-A
promotes proliferation and inhibits apoptosis of gastric cancer.
Hepatogastroenterology. 62:540–545. 2015.PubMed/NCBI
|
|
39
|
Krishnan M, Singh AB, Smith JJ, Sharma A,
Chen X, Eschrich S, Yeatman TJ, Beauchamp RD and Dhawan P: HDAC
inhibitors regulate claudin-1 expression in colon cancer cells
through modulation of mRNA stability. Oncogene. 29:305–312. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
LeBoeuf M, Terrell A, Trivedi S, Sinha S,
Epstein JA, Olson EN, Morrisey EE and Millar SE: Hdac1 and Hdac2
act redundantly to control p63 and p53 functions in epidermal
progenitor cells. Dev Cell. 19:807–818. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Barton ES, Forrest JC, Connolly JL,
Chappell JD, Liu Y, Schnell FJ, Nusrat A, Parkos CA and Dermody TS:
Junction adhesion molecule is a receptor for reovirus. Cell.
104:441–451. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kelly KR, Espitia CM, Zhao W, Wendlandt E,
Tricot G, Zhan F, Carew JS and Nawrocki ST: Junctional adhesion
molecule-A is overexpressed in advanced multiple myeloma and
determines response to oncolytic reovirus. Oncotarget.
6:41275–41289. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Jaime-Ramirez AC, Yu JG, Caserta E, Yoo
JY, Zhang J, Lee TJ, Hofmeister C, Lee JH, Kumar B, Pan Q, et al:
Reolysin and histone deacetylase inhibition in the treatment of
head and neck squamous cell carcinoma. Mol Ther Oncolytics.
5:87–96. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Masuda S, Oda Y, Sasaki H, Ikenouchi J,
Higashi T, Akashi M, Nishi E and Furuse M: LSR defines cell corners
for tricellular tight junction formation in epithelial cells. J
Cell Sci. 124:548–555. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lane AA and Chabner BA: Histone
deacetylase inhibitors in cancer therapy. J Clin Oncol.
27:5459–5468. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang H, Xue W and Jiang X: Overexpression
of TRIM24 stimulates proliferation and glucose metabolism of head
and neck squamous cell carcinoma. Biomed Res Int.
2018:61428432018.PubMed/NCBI
|
|
47
|
Dziedzic A, Kubina R, Kabała-Dzik A and
Tanasiewicz M: Induction of cell cycle arrest and apoptotic
response of head and neck squamous carcinoma cells (Detroit 562) by
caffeic acid and aaffeic acid phenethyl ester derivative. Evid
Based Complement Alternat Med. 2017:67934562017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Grabarska A, Łuszczki JJ, Nowosadzka E,
Gumbarewicz E, Jeleniewicz W, Dmoszyńska-Graniczka M, Kowalczuk K,
Kupisz K, Polberg K and Stepulak A: Histone deacetylase inhibitor
SAHA as potential targeted therapy agent for larynx cancer cells. J
Cancer 2017. 8:19–28. 2017.
|
|
49
|
Li T, Zhang C, Hassan S, Liu X, Song F,
Chen K, Zhang W and Yang J: Histone deacetylase 6 in cancer. J
Hematol Oncol. 11:1112018. View Article : Google Scholar : PubMed/NCBI
|
